Table 2.
Antimicrobial use stratified by receipt of immunosuppression
| Characteristic | Overall, N = 7151 | High-dose immunosuppression | p-value | |
|---|---|---|---|---|
| No, N = 6481 | Yes, N = 671 | |||
| Received any antimicrobial | 606 (85%) | 542 (84%) | 64 (96%) | 0.012 |
| Number of antimicrobial courses | 2 (1, 3) | 2 (1, 3) | 3 (2, 5) | < 0.0013 |
| Antimicrobial Days of Treatment | 8 (4, 14) | 8 (3, 13) | 12 (8, 18) | < 0.0013 |
| Received an Access antibiotic | 504 (70%) | 446 (69%) | 58 (87%) | 0.0022 |
| Received a Watch antibiotic | 429 (60%) | 385 (59%) | 44 (66%) | 0.32 |
| Received a Reserve antibiotic | 45 (6%) | 36 (6%) | 9 (13%) | 0.34 |
| Received an antifungal | 32 (4%) | 24 (4%) | 8 (12%) | 0.0074 |
1Median (IQR) for continuous variables; n (column % of non-missing data) for categorical variables
2Pearson’s Chi-squared test
3Wilcoxon rank sum test
4Fisher’s exact test